Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 208,193 | 199,221 | 198,902 | 188,337 | 181,599 |
| Cost of Goods | 133,513 | 125,772 | 128,917 | 125,588 | 120,565 |
| Gross Profit | 74,680 | 73,449 | 69,985 | 62,749 | 61,034 |
| Operating Expenses | 13,617 | 14,004 | 17,182 | 11,924 | 17,323 |
| Operating Income | 61,576 | 60,217 | 53,720 | 51,413 | 44,276 |
| Interest Expense | 3,651 | 4,015 | 4,114 | 4,059 | 3,988 |
| Other Income | -1,264 | -675 | 0 | 0 | 0 |
| Pre-tax Income | 56,661 | 55,527 | 49,606 | 47,354 | 40,288 |
| Income Tax | 16,671 | 16,764 | 15,244 | 15,068 | 16,511 |
| Net Income Continuous | 39,990 | 38,763 | 34,362 | 32,286 | 23,777 |
| Minority Interests | 48 | 209 | 146 | 81 | 160 |
| Net Income | $39,942 | $38,554 | $34,216 | $32,205 | $23,617 |
| EPS Basic Total Ops | 0.88 | 0.86 | 0.77 | 0.72 | 0.52 |
| EPS Basic Continuous Ops | 0.89 | 0.87 | 0.77 | 0.72 | 0.52 |
| EPS Diluted Total Ops | 0.81 | 0.79 | 0.71 | 0.69 | 0.49 |
| EPS Diluted Continuous Ops | 0.82 | 0.79 | 0.72 | 0.69 | 0.50 |
| EBITDA(a) | $67,355 | $66,031 | $59,486 | $57,167 | $50,457 |